Amplification and in silico Study of Plasmodium vivax and Plasmodium falciparum LDH Gene

Autoři

  • Hetal Kantilal Panchal veer narmad south gujarat university, Surat
  • Ratna A. Trivedi
  • Pratibha B. Desai

Klíčová slova:

LDH, amplification, diagnosis, alignment

Abstrakt

Several arsenal as well as quinolone drugs are available for treatment of malaria; still it remains a worldwide public health problem. Malarial parasite quickly develops resistance under selective drug pressure. Hence, we require an array of new drugs for malaria treatment. Lactate dehydrogenase (LDH) is an essential enzyme for Plasmodia as they lack functional Krebs cycle in some stages of their lifecycle and thereby prove to be good targets for antimalarial drugs. It is also highly valuable for accurate and early malaria diagnosis. In our study, samples were collected from patients before and after treatment. Samples showing > 25% parasitemia after 48 h of treatment were selected for amplification of PvLDH and PfLDH genes. Sequences obtained were aligned with other Plasmodial and human LDH sequences. There was significant dissimilarity found between Plasmodial and human LDH, suggesting it as a good antimalarial target protein. The Plasmodium falciparum and Plasmodium vivax sample strains are phyllogenetically found closely related with P. falciparum isolate mzr I LDH and P. vivax isolate ori I LDH respectively. 

Biografie autora

  • Hetal Kantilal Panchal, veer narmad south gujarat university, Surat
    microbiology dept.

Stažení

Publikováno

2013-02-19

Číslo

Vol 2 No 3 (2012)

Sekce

Research Articles

Licence

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

·         I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.

·         I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).

·         I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.

·          I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

_______________

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.